Submission Details
| 510(k) Number | K101574 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 07, 2010 |
| Decision Date | November 23, 2010 |
| Days to Decision | 169 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
K101574 is an FDA 510(k) clearance for the ARK GABAPENTIN ASSAY, ARK GABEPENTIN CALIFRATOR, AND ARK GABAPENTIN CONTROL MODEL5025-0001-00, 5025-0002-00, 5025-0003-0, a Gabapentin Assay (Class II — Special Controls, product code OTF), submitted by ARK Diagnostics, Inc. (Sunnyvale, US). The FDA issued a Cleared decision on November 23, 2010, 169 days after receiving the submission on June 7, 2010. This device falls under the Toxicology review panel. Regulated under 21 CFR 862.3350.
| 510(k) Number | K101574 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | June 07, 2010 |
| Decision Date | November 23, 2010 |
| Days to Decision | 169 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | OTF — Gabapentin Assay |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 862.3350 |
| Definition | Test For The Quantitative Determination Of Gabapentin In Human Serum Or Plasma. Gabapentin Concentrations Can Be Used As An Aid In Management Of Patients Treated With Gabapentin. |